| | RAD51D, RAD51L3-RFFL (T328I +2 more) | Single nucleotide variant (missense variant +1 more) | not provided +4 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (Q327* +2 more) | Single nucleotide variant (nonsense +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (G325S +2 more) | Single nucleotide variant (missense variant +1 more) | not specified +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (E307K +2 more) | Single nucleotide variant (missense variant +1 more) | Breast and/or ovarian cancer +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | |
| | RAD51L3-RFFL, RAD51D (A293V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (L278P +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | RAD51D-related disorder +2 more | |
| | RAD51L3-RFFL, RAD51D (R266C +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +6 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G265R +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast and/or ovarian cancer +3 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | |
| | RAD51D, RAD51L3-RFFL (R253Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (E233G +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51L3-RFFL, RAD51D (R232Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +4 more | |
| | RAD51D, RAD51L3-RFFL (M227T +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | | Single nucleotide variant (intron variant) | not specified +3 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (V203M +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | |
| | RAD51D, RAD51L3-RFFL (V200M +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (R186* +2 more) | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51L3-RFFL, RAD51D (R165Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +3 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R145H +1 more) | Single nucleotide variant (missense variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +2 more) | RAD51D-related disorder +1 more | |
| | RAD51D, RAD51L3-RFFL (T114fs +1 more) | Duplication (frameshift variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51L3-RFFL, RAD51D (T103A +1 more) | Single nucleotide variant (missense variant +2 more) | RAD51D-related disorder +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | RAD51D-related disorder | |
| | RAD51D, RAD51L3-RFFL (D98fs) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (A96T) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (D90G) | Single nucleotide variant (missense variant +1 more) | RAD51D-related disorder +4 more | |
| | RAD51D, RAD51L3-RFFL (L84H) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (K80R) | Single nucleotide variant (missense variant +1 more) | RAD51D-related disorder | |
| | RAD51D, RAD51L3-RFFL (P64S) | Single nucleotide variant (missense variant +1 more) | RAD51D-related disorder +1 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | RAD51D-related disorder | |
| | RAD51D, RAD51L3-RFFL (A52V) | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (splice donor variant +1 more) | RAD51D-related disorder +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (V66M) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +6 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (F64L) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (A49V) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast and/or ovarian cancer +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (S46P) | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +3 more | |
| | RAD51L3-RFFL, RAD51D (C9S) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | not specified +2 more | GConflicting classifications of pathogenicity |